SMART Implementation-Effectiveness Trial 2
NCT07138027 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2025-09-17
Summary
While single maintenance and reliever therapy (SMART) has been the preferred management strategy for Step 3 and 4 (moderate/severe) asthma management since the 2020 NIH asthma guideline updates, adoption of SMART has not been rigorously assessed. This study will test population health management (PHM; asthma community health worker, asthma nurse care manager) implementation strategies building on electronic medical record clinical decision support and education implementation strategies (CDS+), to increase adoption of SMART. This is the second of two related records.
Conditions
- Asthma in Children
Interventions
- BEHAVIORAL
-
Clinical decision support + education (CDS+) and population health management (PHM)
In Interval 1, intervention clinic providers will experience nudges in the electronic medical record to encourage prescribing SMART where clinically-appropriate and intervention clinic providers, families/patients, and nurses will receive education (collectively CDS+). In Interval 2, intervention clinics will have CDS+ and population health management (PHM) strategies, including an asthma community health worker and an asthma nurse care manager.
- OTHER
-
Control
Clinics in Arm 2 will not be exposed to the interventions.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Children's Hospital of Philadelphia
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-03
- Primary Completion
- 2027-08-31
- Completion
- 2028-02-29
Countries
- United States
Study Locations
More Related Trials
-
Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia
NCT00576316 ·Status: COMPLETED ·Phase: PHASE4
-
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT01647646 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Efficacy of Symbicort® SMART.
NCT00839800 ·Status: COMPLETED ·Phase: PHASE3
-
Improving the Quality of Care for Asthma Patients at Risk of Exacerbations
NCT06596512 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Asthma Implementation Research Trial
NCT03986177 ·Status: COMPLETED ·Phase: NA
-
Titratable Dosing in Moderate to Severe Asthmatics
NCT00651768 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
NCT00524641 ·Status: COMPLETED
-
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
NCT01156792 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of a Smartphone Application for Asthma Self-management
NCT05572177 ·Status: RECRUITING ·Phase: NA
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Does Shared Decision-Making Improve Asthma Outcomes?
NCT00149526 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
NCT03676413 ·Status: COMPLETED ·Phase: PHASE3
-
Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
NCT03461627 ·Status: UNKNOWN ·Phase: PHASE3
-
SMART-School-based Asthma Therapy
NCT06796387 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Interventions to Improve Asthma Management/Prevention at School
NCT00005736 ·Status: COMPLETED
-
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
NCT06261957 ·Status: COMPLETED ·Phase: PHASE3
-
Guidelines to Practice: Reducing Asthma Health Disparities Through Guideline Implementation
NCT02190617 ·Status: UNKNOWN ·Phase: NA
-
Community Intervention for Minority Children With Asthma
NCT00005715 ·Status: COMPLETED
-
Asthma Intervention Research (AIR) Trial
NCT00214526 ·Status: COMPLETED ·Phase: NA
-
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
NCT00319306 ·Status: COMPLETED ·Phase: PHASE3
-
Develop and Implement Asthma Controlling Strategies (2)
NCT00005733 ·Status: COMPLETED